Zydus Gets CDSCO Panel Nod for Phase III Trial of Dextromethorphan, Phenylephrine Cough Syrup FDC We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Union Health Secretary chairs high level meeting with States, UTs on quality, rational use of cough syrups We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
New Delhi: Union health secretary Punya Salila Srivastava held a meeting with principal secretaries and health secretaries of all states and Union territories on Sunday following the cough syrup issue that has rattled the country once again. The meeting was aimed at discussing ways to ensure quality of drugs after multiple child deaths linked to…
Zydus Lifesciences Secures CDSCO Panel Approval for Usnoflast Capsule Interaction Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Sresan Pharma’s Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol Detected We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO Flags MSD Pharma’s Cancer Drug Trial Over Indian Representation, Control Arm We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Trump Warns Pharma Firms of 5-8% Extra Tariffs Ahead of October Drug Pricing Deadline We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link